Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03464279 · ClinicalTrials.gov registry record · NA

Use of a Behavioral Economic Intervention to Reduce Antibiotic Prescription for Upper Respiratory Infections

A NA study, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
2,500
Enrollment target

NCT03464279: Completed NA study, sponsored by University of California, Los Angeles.

NCT03464279 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 2,500 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03464279, a NA study, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
2,500 participants
Enrollment target

Study Summary

In an effort to implement Choosing Wisely guidelines and decrease patient harm, we will implement and evaluate a clinician audit-feedback and behavioral "nudge" initiative to reduce low-value antibiotics for URIs. Using a quasi-experiment (pre-post) design, antibiotic prescriptions for URI at LAC+USC Urgent Care Center (intervention site) vs. Olive View-UCLA Urgent Care Center (control site) will used to test the effects of behavioral "nudge" on antibiotic prescribing.

Primary Outcome

Changes in inappropriate antibiotic prescriptions rates per visit before and after implementation of intervention at both sites

Interventions

  • BEHAVIORAL Nudge using Behavioral Economic Interventions
  • BEHAVIORAL Standard Practices to Reduce Health System Antibiotic Prescription

Trial Details

FieldValue
Enrollment Target 2,500 participants
Start Date 2015-05-29
Est. Completion 2018-03-30
Phase NA

What the finished NCT03464279 record still lists

NCT03464279 is an interventional study that assigns participants to a tested intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% higher).

The record links to 0 conditions, and to 2 interventions - of which Nudge using Behavioral Economic Interventions is the first listed.

NCT03464279 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03464279 about?

NCT03464279 is a clinical study titled "Use of a Behavioral Economic Intervention to Reduce Antibiotic Prescription for Upper Respiratory Infections". In an effort to implement Choosing Wisely guidelines and decrease patient harm, we will implement and evaluate a clinician audit-feedback and behavioral "nudge" initiative to reduce low-value antibiotics for URIs. Using a quasi-experiment (pre-post) design, antibiotic prescriptions for URI at LAC+US...

What is the current status of trial NCT03464279?

This trial is currently completed. It is a NA study. The enrollment target is 2,500 participants. The study started on 2015-05-29. Estimated completion is 2018-03-30.

What interventions are being tested in trial NCT03464279?

The interventions under investigation include: Nudge using Behavioral Economic Interventions (BEHAVIORAL), Standard Practices to Reduce Health System Antibiotic Prescription (BEHAVIORAL).

Who is sponsoring clinical trial NCT03464279?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03464279's enrollment target sits among peer trials

2,500 44th of 2000 higher than 1,956 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001160 · 2,500 participants

    Studies on Tumors of the Thyroid

  • NCT01904188 · 2,500 participants

    Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?

  • NCT02257229 · 2,500 participants

    Prospective Evaluation of Treatment for Clubfoot

  • NCT02530658 · 2,500 participants

    Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03464279, the US trial registry maintained by the National Library of Medicine. NCT03464279 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.